Double Voiding and Post-transplant UTI
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorWeill Medical College of Cornell University
About this trial
Urinary tract infections (UTI) are common in kidney transplant recipients and are an important cause of illness and hospital admissions. Past studies have shown that about 1 out of 5 of newly transplanted patients develop UTI within their first 3 months of transplantation. Such UTIs increase the risk for blood stream infection and acute rejection of the kidney, Improvements in urinary voiding techniques may reduce the frequency of UTI. The purpose of this study is to evaluate the benefits of "double voiding" in kidney transplant recipients.
Eligibility criteria
Qualifiers
All adult kidney transplant recipients who undergo routine follow-up at the New York Presbyterian - Weill Cornell Medicine (NYP-WCM) Transplant Clinic.
Disqualifiers
Kidney transplant recipients who are discharged after a transplant with an indwelling catheter (Foley)
Trial design
Treatments tested in this trial
- Double Voiding
- Regular Voiding
Treatment groups
438 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov